Healthcare -
Biotechnology - NASDAQ - US
$ 13.08
0.615 %
$ 1.12 B
Market Cap
-3.59
P/E
Price Target
Average
148.47%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
27.85%
Net Income
Estimate
41.96%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Syndax Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for SNDX of $32.5 , with forecasts ranging from
a
low of
$18 to a high of $40 .
SNDX Lowest Price Target
Wall Street Target
18 USD
37.61%
SNDX Average Price Target
Wall Street Target
32.5 USD
148.47%
SNDX Highest Price Target
Wall Street Target
40 USD
205.81%
REVENUE FORECAST
Revenue Forecast Chart SNDX
EBIT FORECAST
EBIT Forecast Chart SNDX
NET INCOME FORECAST
Net Income Chart SNDX